Clinical Trial Update: A Clinical Trial of Study Medicine (Marstacimab) in Pediatric Patients With Hemophilia A or Hemophilia B [Phase 3]

View source ↗

Summary

Pfizer's Marstacimab is studied in a Phase 3 trial in pediatric patients with Hemophilia A or Hemophilia B and is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hemophilia

Drugs mentioned

• Marstacimab (Marstacimab)

Snippet

Sponsor: Pfizer | Conditions: Hemophilia A, Hemophilia B | Phase 3 | Status: RECRUITING